BlossomHill Therapeutics, Inc. ($BLSM)
Filing Information
| Accession Number | 0002143905-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 10, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
96,635
Total Value
$74,700.00
P&L
+1014.4% (+$757,778.64)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Aug 7, 2026 | Purchase | 2,500 | $15.80 | $39,500.00 | 109,212 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 10, 2026 | Purchase | 2,200 | $16.00 | $35,200.00 | 111,412 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 10, 2026 | Conversion | 22,687 | โ | โ | 22,687 | Indirect | By Walter T. Liptak Revocable Trust | View Details | |
General Counsel | Employee Stock Option (Right to Buy) | Derivative | Aug 6, 2026 | Grant/Award | 46,561 | $0.00 | $0.00 | 46,561 | Direct | โ | View Details | |
General Counsel | Series B Preferred Stock | Derivative | Aug 10, 2026 | Conversion | 22,687 | โ | โ | 0 | Indirect | By Walter T. Liptak Revocable Trust | View Details |